Items where authors include "Phillips, D."

Export as [feed] Atom [feed] RSS
Number of items: 5.

Article

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Whyte, M.P., Simmons, J.H., Moseley, S. et al. (7 more authors) (2019) Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial. Lancet Diabetes and Endocrinology, 7 (2). pp. 93-105. ISSN 2213-8587

Phillips, D., Hagan, T., Bodfield, E. et al. (2 more authors) (2008) Exploring the impact of group work and mentoring for multiple heritage children's self-esteem, well-being and behaviour. Health and Social Care in the Community, 16 (3). pp. 310-321. ISSN 1365-2524

Proceedings Paper

Rawstron, A., Webster, N., Dalal, S. et al. (15 more authors) (2023) Using Peripheral Blood (PB) Measurable Residual Disease (MRD) Levels to Predict <0.01% Bone Marrow Disease (BM uMRD4): Identification of Effective PB Targets for CLL Treatment Cessation in the Ibrutinib+Venetoclax Arm of the FLAIR Trial. In: Blood. 65th ASH: Annual Meeting & Exposition, 09-12 Dec 2023, San Diego, USA. American Society of Hematology , p. 632.

This list was generated on Sun Mar 24 13:14:09 2024 GMT.